504 related articles for article (PubMed ID: 22467679)
1. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.
Sihto H; Böhling T; Kavola H; Koljonen V; Salmi M; Jalkanen S; Joensuu H
Clin Cancer Res; 2012 May; 18(10):2872-81. PubMed ID: 22467679
[TBL] [Abstract][Full Text] [Related]
2. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma.
Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
Clin Cancer Res; 2011 Jul; 17(14):4806-13. PubMed ID: 21642382
[TBL] [Abstract][Full Text] [Related]
3. A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma.
Walsh NM; Fleming KE; Hanly JG; Dakin Hache K; Doucette S; Ferrara G; Cerroni L
Hum Pathol; 2016 Jun; 52():190-6. PubMed ID: 26980039
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Role of Tumoral PD-L1 and IDO1 Expression, and Intratumoral CD8+ and FoxP3+ Lymphocyte Infiltrates in 132 Primary Cutaneous Merkel Cell Carcinomas.
Donizy P; Wu CL; Kopczynski J; Pieniazek M; Biecek P; Ryś J; Hoang MP
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071045
[TBL] [Abstract][Full Text] [Related]
5. Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.
Iyer JG; Afanasiev OK; McClurkan C; Paulson K; Nagase K; Jing L; Marshak JO; Dong L; Carter J; Lai I; Farrar E; Byrd D; Galloway D; Yee C; Koelle DM; Nghiem P
Clin Cancer Res; 2011 Nov; 17(21):6671-80. PubMed ID: 21908576
[TBL] [Abstract][Full Text] [Related]
6. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma.
Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
J Natl Cancer Inst; 2009 Jul; 101(13):938-45. PubMed ID: 19535775
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of MCPyV and TIL Subtyping in Merkel Cell Carcinoma: Evidence from a Large European Cohort of 95 Patients.
Ricci C; Righi A; Ambrosi F; Gibertoni D; Maletta F; Uccella S; Sessa F; Asioli S; Pellilli M; Maragliano R; La Rosa S; Papotti MG; Asioli S
Endocr Pathol; 2020 Mar; 31(1):21-32. PubMed ID: 31808008
[TBL] [Abstract][Full Text] [Related]
8. Detection of Merkel cell polyomavirus and human papillomaviruses in Merkel cell carcinoma combined with squamous cell carcinoma in immunocompetent European patients.
Mitteldorf C; Mertz KD; Fernández-Figueras MT; Schmid M; Tronnier M; Kempf W
Am J Dermatopathol; 2012 Jul; 34(5):506-10. PubMed ID: 22505039
[TBL] [Abstract][Full Text] [Related]
9. No evidence for a causal role of Merkel cell polyomavirus in keratoacanthoma.
Wieland U; Scola N; Stolte B; Stücker M; Silling S; Kreuter A
J Am Acad Dermatol; 2012 Jul; 67(1):41-6. PubMed ID: 21996295
[TBL] [Abstract][Full Text] [Related]
10. Merkel cell polyomavirus DNA detection in lesional and nonlesional skin from patients with Merkel cell carcinoma or other skin diseases.
Foulongne V; Dereure O; Kluger N; Molès JP; Guillot B; Segondy M
Br J Dermatol; 2010 Jan; 162(1):59-63. PubMed ID: 19678822
[TBL] [Abstract][Full Text] [Related]
11. Detection of Merkel cell polyomavirus DNA in atypical fibroxanthoma in correlation to clinical features.
Andres C; Puchta U; Flaig MJ
Am J Dermatopathol; 2010 Dec; 32(8):799-803. PubMed ID: 20861707
[TBL] [Abstract][Full Text] [Related]
12. The new polyomavirus (MCPyV) does not affect the clinical course in MCCs.
Handschel J; Müller D; Depprich RA; Ommerborn MA; Kübler NR; Naujoks C; Reifenberger J; Schäfer KL; Braunstein S
Int J Oral Maxillofac Surg; 2010 Nov; 39(11):1086-90. PubMed ID: 20678899
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of significant morphologic characteristics in distinguishing between Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative Merkel cell carcinomas.
Iwasaki T; Matsushita M; Kuwamoto S; Kato M; Murakami I; Higaki-Mori H; Nakajima H; Sano S; Hayashi K
Hum Pathol; 2013 Sep; 44(9):1912-7. PubMed ID: 23664542
[TBL] [Abstract][Full Text] [Related]
14. Lower expression of CADM1 and higher expression of MAL in Merkel cell carcinomas are associated with Merkel cell polyomavirus infection and better prognosis.
Iwasaki T; Matsushita M; Nonaka D; Nagata K; Kato M; Kuwamoto S; Murakami I; Hayashi K
Hum Pathol; 2016 Feb; 48():1-8. PubMed ID: 26772392
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival.
Miller NJ; Church CD; Dong L; Crispin D; Fitzgibbon MP; Lachance K; Jing L; Shinohara M; Gavvovidis I; Willimsky G; McIntosh M; Blankenstein T; Koelle DM; Nghiem P
Cancer Immunol Res; 2017 Feb; 5(2):137-147. PubMed ID: 28093446
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin expressions are only associated with MCPyV-positive Merkel cell carcinomas but not with MCPyV-negative ones: comparison of prognosis.
Murakami I; Takata K; Matsushita M; Nonaka D; Iwasaki T; Kuwamoto S; Kato M; Mohri T; Nagata K; Kitamura Y; Yoshino T; Hayashi K
Am J Surg Pathol; 2014 Dec; 38(12):1627-35. PubMed ID: 25392922
[TBL] [Abstract][Full Text] [Related]
17. Human polyomaviruses 6 and 7 are not detectable in Merkel cell polyomavirus-negative Merkel cell carcinoma.
Duncavage EJ; Pfeifer JD
J Cutan Pathol; 2011 Oct; 38(10):790-6. PubMed ID: 21883367
[TBL] [Abstract][Full Text] [Related]
18. Presence of Merkel cell polyomavirus in Japanese cutaneous squamous cell carcinoma.
Murakami M; Imajoh M; Ikawa T; Nakajima H; Kamioka M; Nemoto Y; Ujihara T; Uchiyama J; Matsuzaki S; Sano S; Daibata M
J Clin Virol; 2011 Jan; 50(1):37-41. PubMed ID: 20965777
[TBL] [Abstract][Full Text] [Related]
19. Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma.
Feldmeyer L; Hudgens CW; Ray-Lyons G; Nagarajan P; Aung PP; Curry JL; Torres-Cabala CA; Mino B; Rodriguez-Canales J; Reuben A; Chen PL; Ko JS; Billings SD; Bassett RL; Wistuba II; Cooper ZA; Prieto VG; Wargo JA; Tetzlaff MT
Clin Cancer Res; 2016 Nov; 22(22):5553-5563. PubMed ID: 27166398
[TBL] [Abstract][Full Text] [Related]
20. Merkel polyomavirus-specific T cells fluctuate with merkel cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.
Afanasiev OK; Yelistratova L; Miller N; Nagase K; Paulson K; Iyer JG; Ibrani D; Koelle DM; Nghiem P
Clin Cancer Res; 2013 Oct; 19(19):5351-60. PubMed ID: 23922299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
